Inventiva (IVA) Common Equity (2018 - 2025)

Inventiva's (IVA) quarterly Common Equity came in at -$33.2 million in Q4 2025, up 70.87% year-on-year from -$19.4 million in Q4 2024, and up 99.67% quarter-over-quarter from -$10.1 billion in Q2 2025.

Inventiva (IVA) Common Equity (2018 - 2025) Analysis & Trends

Inventiva's Common Equity history runs 8 years deep, the most recent figure standing at -$33.2 million for Q4 2025.

  • On a quarterly basis, Common Equity rose 70.87% year-over-year to -$33.2 million in Q4 2025; TTM through Dec 2025 was -$33.2 million, a 70.87% increase from a year earlier, with the FY2025 full-year figure at -$33.2 million, up 70.87% from the prior year.
  • Common Equity advanced to -$33.2 million in Q4 2025 per IVA's latest filing, from -$10.1 billion in the prior quarter.
  • Across five years, Common Equity topped out at $217.4 billion in Q2 2024 and bottomed at -$10.1 billion in Q2 2025.
  • The 5-year median for Common Equity is $74.0 million (2021), against an average of $39.3 billion.
  • Across the five-year window, Common Equity surged 69694.74% in 2022 and sank 230.67% in 2024, its largest moves.
  • Year by year, Common Equity stood at $101.7 million in 2021, then tumbled by 54.36% to $46.4 million in 2022, then plunged by 174.28% to -$34.5 million in 2023, then slumped by 230.67% to -$114.0 million in 2024, then jumped by 70.87% to -$33.2 million in 2025.
  • Per Business Quant, the three latest IVA Common Equity figures stand at -$33.2 million (Q4 2025), -$10.1 billion (Q2 2025), and -$114.0 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 251.12 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -98.34 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 4.76 Bn
4 NuCana 279.75 Bn 279.75 Bn - 32.36 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 19.36 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 31.42 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 795.79 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 1.50 Bn
10 Inventiva 842.48 Mn 842.48 Mn - -33.20 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -33.20 Mn
Jun 30, 2025 -10.08 Bn
Dec 31, 2024 -113.96 Mn
Jun 30, 2024 217.38 Bn
Dec 31, 2023 -34.46 Mn
Oct 11, 2023 24.55 Mn
Jun 30, 2023 189.35 Bn
Dec 31, 2022 46.40 Mn
Jun 30, 2022 74.40 Bn
Dec 31, 2021 101.66 Mn
Jun 30, 2021 106.60 Mn
Mar 31, 2021 123.34 Mn
Dec 31, 2020 132.60 Mn
Jun 30, 2020 45.97 Mn
Dec 31, 2019 45.82 Mn
Dec 31, 2018 70.31 Mn